A systematic study of immune system gene expression in healthy aging and in AD cases, in a region‐ and gender‐specific manner, concluded that there is a critical involvement of inflammation in the preclinical stage of AD with both caspase‐1 and IL‐1β up‐regulated (Cribbs et al., 2012). The gene discussed is IL1B; the disease is Alzheimer disease.